The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update
Open accessAbstract
The purpose of this guideline is to provide information for the interpretation of clinical dihydropyrimidine dehydrogenase (DPYD) genotype tests so that the results can be used to guide dosing of fluoropyrimidines (5‐fluorouracil and capecitabine). Detailed guidelines for the use of fluoropyrimidines, their clinical pharmacology, as well as analyses of cost‐effectiveness are beyond the scope of this document. The Clinical Pharmacogenetics Implementation Consortium (CPIC®) guidelines consider the situation of patients for which genotype data are already available (updates available at https://cpicpgx.org/guidelines/guideline‐for‐fluoropyrimidines‐and‐dpyd/).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
Relling, M. V., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.279 · Cited by 1,164
Self-citationPharmacogenetics: From Bench to Byte— An Update of Guidelines
Swen, J. J., Nijenhuis, M., de Boer, A., Grandia, L., Maitland-van der Zee, A. H., Mulder, H., Rongen, G. A. P. J. M., van Schaik, R. H. N., Schalekamp, T., Touw, D. J., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.34 · Cited by 1,018
Self-citationClinical Pharmacology of 5-Fluorouracil
Diasio, R. B., & Harris, B. E. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916040-00002 · Cited by 969
Self-citationDiasio, R. B., Beavers, T. L., & Carpenter, J. T. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113308 · Cited by 503
Self-citationSchwab, M., Zanger, U. M., Marx, C., Schaeffeler, E., Klein, K., Dippon, J., Kerb, R., Blievernicht, J., Fischer, J., Hofmann, U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4182 · Cited by 393
Self-citationMeulendijks, D., Henricks, L. M., Sonke, G. S., Deenen, M. J., Froehlich, T. K., Amstutz, U., Largiadèr, C. R., Jennings, B. A., Marinaki, A. M., Sanderson, J. D., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00286-7 · Cited by 381
Self-citationUpfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis
Deenen, M. J., Meulendijks, D., Cats, A., Sechterberger, M. K., Severens, J. L., Boot, H., Smits, P. H., Rosing, H., Mandigers, C. M. P. W., Soesan, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1325 · Cited by 360
Self-citationGamelin, E., Delva, R., Jacob, J., Merrouche, Y., Raoul, J. L., Pezet, D., Dorval, E., Piot, G., Morel, A., & Boisdron-Celle, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3934 · Cited by 346
Rosmarin, D., Palles, C., Church, D., Domingo, E., Jones, A., Johnstone, E., Wang, H., Love, S., Julier, P., Scudder, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.1857 · Cited by 256
Self-citationMorel, A., Boisdron-Celle, M., Fey, L., Soulie, P., Craipeau, M. C., Traore, S., & Gamelin, E. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0327 · Cited by 236
Fleming, R. A., Milano, G. A., Thyss, A., Étienne-Grimaldi, M.-C., Renée, N., Schneider, M., & Demard, F. (1992) · PubMed · Cited by 235
Deenen, M. J., Tol, J., Burylo, A. M., Doodeman, V. D., de Boer, A., Vincent, A., Guchelaar, H.-J., Smits, P. H. M., Beijnen, J. H., Punt, C. J. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2209 · Cited by 191
Self-citationLee, A. M., Shi, Q., Pavey, E., Alberts, S. R., Sargent, D. J., Sinicrope, F. A., Berenberg, J. L., Goldberg, R. M., & Diasio, R. B. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju298 · Cited by 189
Self-citationOffer, S. M., Fossum, C. C., Wegner, N. J., Stuflesser, A. J., Butterfield, G. L., & Diasio, R. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2482 · Cited by 184
Self-citationFroehlich, T. K., Amstutz, U., Aebi, S. P., Joerger, M., & Largiadèr, C. R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29025 · Cited by 155
Self-citationOffer, S. M., Wegner, N. J., Fossum, C. C., Wang, K., & Diasio, R. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3858 · Cited by 121
Self-citationTranslating DPYD Genotype into DPD Phenotype: Using the DPYD Gene Activity Score
Henricks, L. M., Lunenburg, C. A. T. C., Meulendijks, D., Gelderblom, H. A. J., Cats, A., Swen, J. J., Schellens, J. H. M., & Guchelaar, H. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.70 · Cited by 114
Self-citationInborn errors of pyrimidine degradation: Clinical, biochemical and molecular aspects
Gennip, A. H., Abeling, N. G. G. M., Vreken, P., & Kuilenburg, A. B. P. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005356806329 · Cited by 112
Offer, S. M., Lee, A. M., Mattison, L. K., Fossum, C., Wegner, N. J., & Diasio, R. B. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.69 · Cited by 102
Self-citationMeulendijks, D., Cats, A., Beijnen, J. H., & Schellens, J. H. M. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.08.002 · Cited by 102
Self-citationOffer, S. M., Butterfield, G. L., Jerde, C. R., Fossum, C. C., Wegner, N. J., & Diasio, R. B. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0878 · Cited by 88
Self-citationBoisdron‐Celle, M., Capitain, O., Faroux, R., Borg, C., Metges, J. P., Galais, M., Kaassis, M., Bennouna, J., Bouhier‐Leporrier, K., François, É., et al. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.02.008 · Cited by 85
Inborn errors of purine and pyrimidine metabolism
Jurecka, A. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1094-z · Cited by 77
Nie, Q., Shrestha, S., Tapper, E. J., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.685 · Cited by 69
Predicting 5-Fluorouracil Toxicity: DPD Genotype and 5,6-Dihydrouracil: Uracil Ratio
Sistonen, J., Büchel, B., Froehlich, T. K., Kummer, D., Fontana, S., Joerger, M., Kuilenburg, A. B. P., & Largiadèr, C. R. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.126 · Cited by 62
Patel, J. N., O’Neil, B. H., Deal, A. M., Ibrahim, J. G., Sherrill, G. B., Olajide, O., Atluri, P. M., Inzerillo, J. J., Chay, C. H., McLeod, H. L., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0132 · Cited by 50
Self-citationPolymorphisms in MIR27A Associated with Early-Onset Toxicity in Fluoropyrimidine-Based Chemotherapy
Amstutz, U., Offer, S. M., Sistonen, J., Joerger, M., Diasio, R. B., & Largiadèr, C. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2817 · Cited by 41
Self-citationPhase I study of 5-fluorouracil in children and young adults with recurrent ependymoma
Wright, K. D., Daryani, V. M., Turner, D. C., Onar‐Thomas, A., Boulos, N., Orr, B. A., Gilbertson, R. J., Stewart, C. F., & Gajjar, A. J. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov181 · Cited by 33
Fang, L., Xin, W., Ding, H., et al. (2016) · Scientific Reports · doi:10.1038/srep25913 · Cited by 19
Cited by
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
Biller, L. H., & Schrag, D. (2021) · JAMA · doi:10.1001/jama.2021.0106 · Cited by 2,604
Henricks, L. M., Lunenburg, C. A. T. C., de Man, F. M., Meulendijks, D., Frederix, G. W. J., Kienhuis, E., Creemers, G.-J., Baars, A., Dezentjé, V. O., Imholz, A. L. T., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30686-7 · Cited by 444
Self-citationColon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Adam, M., Chang, G., Chen, Y.-J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2024) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2024.0029 · Cited by 371
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
A narrative review of genetic factors affecting fluoropyrimidine toxicity
Gmeiner, W. H. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-17 · Cited by 25
Metadata
- Authors
- Amstutz, U., Henricks, L. M., Offer, S. M., Barbarino, J., Schellens, J. H. M., Swen, J. J., Klein, T. E., McLeod, H. L., Caudle, K. E., Diasio, R. B., & Schwab, M.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2017-11-20
- Volume
- 103
- Issue
- 2
- Pages
- 210-216
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2770862842
- Cited by
- 694
- References
- 31
- FWCI
- 40.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.